✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of ponezumab (PF-04360365) following a single-dose intravenous infusion in patients with mild to moderate Alzheimer's disease

✍ Scribed by Qinying Zhao; Jaren Landen; Aaron H. Burstein; Frederick McCush; Christine Alvey; Clare B. Billing; Wendy W. Ma; James W. Kupiec; Martin M. Bednar

Book ID: 118466221
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 43 KB
Volume: 6
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2010.05.439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of ponezumab (PF-043603

Pharmacokinetics of ponezumab (PF-04360365) following a single-dose intravenous infusion in Japanese patients with mild-to-moderate Alzheimer's disease: Preliminary results

✍ Qinying Zhao; Sadahiro Abe; Izuru Miyoshi; Martin M. Bednar; James W. Kupiec; Yo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Safety and pharmacokinetics following a

Safety and pharmacokinetics following a single 10-minute intravenous infusion of the anti-amyloid mAb ponezumab (PF-04360365) in patients with mild to moderate Alzheimer's disease

✍ Burstein, Aaron H.; Zhao, Qinying; Ross, Joel; Styren, Scot; Landen, Jaren W.; M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Safety of the anti-amyloid monoclonal an

Safety of the anti-amyloid monoclonal antibody ponezumab (PF-04360365) following a single-dose intravenous infusion in Japanese patients with mild-to-moderate Alzheimer's disease: Preliminary results

✍ Yoko Fujimoto; Izuru Miyoshi; Taro Ishibashi; Kanae Togo; Sadahiro Abe; James W. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Safety, tolerability, pharmacokinetics a

Safety, tolerability, pharmacokinetics and pharmacodynamics of monthly and quarterly doses of Ponezumab (PF-04360365) in subjects with mild-to-moderate Alzheimer's disease

✍ Landen, Jaren; Andreasen, Niels; Cronenberger, Carol; Schwartz, Pam; Börjesson-H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Safety and Pharmacokinetics Following a

Safety and Pharmacokinetics Following a Single Infusion of the Anti-amyloid Monoclonal Antibody Ponezumab (pf-04360365) in Patients With Mild-to-moderate Alzheimer's Disease: Final Results

✍ Landen, Jaren W.; Zhao, Qinying; Cohen, Sharon; Borrie, Michael; Woodward, Micha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of bapineuzumab following multiple intravenous infusions in patients with mild-to-moderate Alzheimer's disease

✍ Raskind, Murray; Liang, Earvin; Sperling, Reisa; Boxer, Adam; Ross, Joel; Brody, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB